Manitowoc Flies 55% Past Analyst Target After Earnings Beat

Why this matters: MTW has rallied 41% in one week and now trades at $20.16 — 55% above the analyst consensus price target of $13. The earnings beat triggered a sharp short retreat. Options traders remain conspicuously bullish. Three distinct data streams are now pointing in the same direction.

The Gap That Defines This Trade

Barclays lifted its price target to $16 on August 10. It held its Underweight rating. The stock was already at $20. That gap — between where analysts think the stock belongs and where it's trading — is the defining tension here.

The mean analyst target sits at $13. MTW closed at $20.16 on August 12. That's a 55% premium to consensus. No analyst has a Buy rating. Every major coverage firm has an Underweight or Neutral.

Yet the market keeps pushing higher.

Options Bulls Aren't Backing Down

The put/call ratio read 0.0618 on August 12. The 20-day average is 0.0263. That puts the PCR 2.2 standard deviations above the mean — meaning call buying is running well above recent norms even after the stock's massive post-earnings run.

Before the earnings print on August 6, the PCR sat near its 52-week floor of 0.014. Bulls loaded up on calls heading in. The stock jumped 32% the day after results. The PCR has since ticked up — but it remains historically low in absolute terms, reflecting continued call dominance over put hedging.

Converging Signals

Short interest is retreating. SI dropped 12.5% over the past week to 2.9% of free float. That's down from July peaks when roughly 1.32 million shares were short. Shorts have been cutting exposure steadily since the earnings move.

Cost to borrow has risen despite that retreat. CTB hit 1.29% on August 12, up 58% week-on-week and more than double its level a month ago. That's an unusual combination — fewer shorts, but a pricier borrow. It may reflect lenders repricing for a stock that's moved violently.

Borrow availability remains extremely loose. Availability sits at the data ceiling — there is no shortage of shares to borrow. This is not a supply-constrained short squeeze setup. The CTB rise is modest in absolute terms.

The ORTEX short score has fallen. It dropped from 38.4 on August 4 to 35.6 on August 11. The score measures short-side pressure. It's moving in the same direction as the short interest: down.

BlackRock added 283,712 shares as of July 31, lifting its holding to 4.08 million shares — 11.3% of the company. That's the most recent institutional move of note.

Data Summary

• Price: $20.16, +41% week-on-week, +58% month-on-month
• Analyst consensus target: $13.00 — stock trades 55% above
• Barclays: Raised PT to $16 (from $11), maintained Underweight, Aug 10
• SI % of free float: 2.9%, down 12.5% week-on-week
• PCR: 0.0618 — 2.2 standard deviations above 20-day mean
• Cost to borrow: 1.29%, +58% week-on-week
• Borrow availability: Extremely loose
• Short score: 35.6, falling from 38.4 over the past week
• Next earnings: November 6